TNFRSF1B and neoplasm: Since the majority of tumor-infiltrating Tregs are highly immunosuppressive TNFR2+ Tregs [13,27,28], we thus further examined if TNFR2-targeted nanoparticles could enhance the binding with tumor-infiltrating Tregs.